Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET/CT Imaging”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06911697
What this trial is testing

Study on c-Met Targeted PET/CT Imaging in NSCLC

Who this might be right for
PET/CT ImagingNSCLC
Xilin Sun 88
Very early researchLooking for participantsNCT06914999
What this trial is testing

Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+13 more
Emory University
Not applicableUnknownNCT04626206
What this trial is testing

Multi -paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases

Who this might be right for
Brain Metastases, Adult
Royal Marsden NHS Foundation Trust 12
Not applicableLooking for participantsNCT07707232
What this trial is testing

Large Language Model-Assisted cTNM Annotation From Chinese PSMA PET/CT Reports

Who this might be right for
Prostate Cancer
First Affiliated Hospital of Wenzhou Medical University 4,600
Testing effectiveness (Phase 2)Active Not RecruitingNCT05226663
What this trial is testing

A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer

Who this might be right for
Breast Carcinoma
M.D. Anderson Cancer Center 36
Not applicableNot Yet RecruitingNCT06487767
What this trial is testing

The Validity of the Use of Imaging in Cervical Cancer Staging

Who this might be right for
Cervical Cancer Stage, Imaging Modalities
University of Pretoria 100
Not applicableNot Yet RecruitingNCT07510867
What this trial is testing

18F-FAPI PET/CT and MRI in Gastric Cancer

Who this might be right for
Gastric Cancer
First Affiliated Hospital of Zhejiang University 230
Not applicableEnded earlyNCT04685798
What this trial is testing

Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT

Who this might be right for
Squamous Cell Carcinoma
Washington University School of Medicine 8
Early research (Phase 1)Ended earlyNCT04258592
What this trial is testing

18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

Who this might be right for
Neural Crest TumorNeuroendocrine Tumors
Universitaire Ziekenhuizen KU Leuven 6
Not applicableEnrolling By InvitationNCT06610695
What this trial is testing

PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Cholestatic Disorders in Patients with Genetic Liver Disorders and Healthy Individuals

Who this might be right for
CholestasisGenetic Liver Disorder
University of Aarhus 22
Not applicableNot Yet RecruitingNCT07259941
What this trial is testing

PET-CT in Lymphoma Among the Eldery

Who this might be right for
PET-CTLymphomaElderly+1 more
Assiut University 63
Very early researchUnknownNCT05543954
What this trial is testing

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients

Who this might be right for
Lung Neoplasms
Peking Union Medical College Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03125629
What this trial is testing

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

Who this might be right for
Cancer DiagnosisDiagnostic Techniques and ProceduresDiagnostic Imaging
Stanford University 53
Early research (Phase 1)Study completedNCT01051479
What this trial is testing

A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Wake Forest University Health Sciences 22
Not applicableLooking for participantsNCT07529002
What this trial is testing

Clinical Application of 89Zr-s-C1 PET/CT Imaging in Solid Tumors

Who this might be right for
Solid Tumors
Peking University Cancer Hospital & Institute 20
Not applicableStudy completedNCT01276483
What this trial is testing

Treatment Response Evaluation in Gastrointestinal Stromal Tumor (GIST) Patients

Who this might be right for
Soft Tissue NeoplasmsGastrointestinal Tract
Oslo University Hospital 40
Early research (Phase 1)Ended earlyNCT03029988
What this trial is testing

An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.

Who this might be right for
Liver MetastasesColorectal Carcinoma
Navidea Biopharmaceuticals 3
Large-scale testing (Phase 3)Looking for participantsNCT07444723
What this trial is testing

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

Who this might be right for
Primary HyperparathyroidismParathyroid CancerMultiple Endocrine Neoplasias+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 193
Not applicableUnknownNCT06054789
What this trial is testing

Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer

Who this might be right for
Prostate Cancer
Nanjing First Hospital, Nanjing Medical University 8
Large-scale testing (Phase 3)Study completedNCT03673943
What this trial is testing

Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE

Who this might be right for
Neuroendocrine Tumors
Radiomedix, Inc. 63
Next Page
20